A 12-Month Open-Label Extension Study of the Safety and Tolerability of Lisdexamfetamine Dimesylate for Major Depressive Disorder in Adults

PURPOSE/BACKGROUND: Psychostimulant augmentation is considered a potential treatment strategy for individuals with major depressive disorder who do not adequately respond to antidepressant monotherapy. The primary objective of this 12-month open-label extension study was to evaluate the safety and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Richards, Cynthia, Iosifescu, Dan V., Mago, Rajnish, Sarkis, Elias, Geibel, Brooke, Dauphin, Matthew, McIntyre, Roger S., Weisler, Richard, Brawman-Mintzer, Olga, Gu, Joan, Madhoo, Manisha
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2018
Materias:
Original Contributions
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039401/
https://www.ncbi.nlm.nih.gov/pubmed/29912786
http://dx.doi.org/10.1097/JCP.0000000000000897

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6039401/
https://www.ncbi.nlm.nih.gov/pubmed/29912786
http://dx.doi.org/10.1097/JCP.0000000000000897

Ejemplares similares